Raajit K. Rampal, MD, PhD

Associate Attending

Raajit K. Rampal, MD, PhD

Associate Attending
Share
Share
Raajit K. Rampal, MD, PhD

Office Phone

212-639-2194 (For patient-related issues)

Lab Phone

646-888-2796 (For non-clinical issues only)

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Raajit K. Rampal discloses the following relationships and financial interests:

  • AbbVie
    Professional Services and Activities
  • American Society of Hematology
    Professional Services and Activities
  • Boxer Capital, LLC
    Professional Services and Activities
  • Chinese Academy of Medical Sciences
    Professional Services and Activities
  • Cogent Biosciences, Inc.
    Professional Services and Activities
  • CTI BioPharma Corp.
    Professional Services and Activities
  • GlaxoSmithKline
    Professional Services and Activities
  • Incyte
    Professional Services and Activities
  • Jubilant Therapeutics Inc.
    Professional Services and Activities
  • MorphoSys AG
    Professional Services and Activities
  • MPN Research Foundation
    Professional Services and Activities
  • Noble Insights
    Professional Services and Activities
  • PharmaEssentia
    Professional Services and Activities
  • Protagonist Therapeutics, Inc.
    Professional Services and Activities
  • Sumitomo Pharma
    Professional Services and Activities

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures